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Abstract
The chemical synthesis of molecular probes to identify and study membrane proteins involved in the biological pathway of protein
glycosylation is described. Two short-chain glycolipid analogs that mimic the naturally occurring substrate mannosyl phosphoryl
dolichol exhibit either photoreactive and clickable properties or allow the use of a fluorescence readout. Both probes consist of a
hydrophilic mannose headgroup that is linked to a citronellol derivative via a phosphodiester bridge. Moreover, a novel phosphor-
amidite chemistry-based method offers a straightforward approach for the non-enzymatic incorporation of the saccharide moiety in
an anomerically pure form.
Introduction
Mannosyl phosphoryl dolichol (MPD), an important, multifunc-
tional glycolipid, is used as a mannose donor for protein
N-glycosylation, O- and C-mannosylation, and glycosylphos-
phatidylinositol (GPI) anchoring in the luminal leaflet of the
endoplasmic reticulum (ER) [1-8]. Interestingly, MPD is syn-
thesized on the cytoplasmic face of the ER and must be translo-
cated across the ER membrane to participate in luminal glyco-
syltransfer reactions [3,4]. A specific membrane protein – MPD
scramblase – is required to facilitate the transbilayer movement
of MPD across the ER. Although the activity of MPD scram-
blase has been described in microsomal vesicles and reconsti-
tuted systems [1,2,9], the molecular identity of this protein
remains unknown. To circumvent the need for traditional purifi-
cation strategies to identify the scramblase, we considered the
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Figure 1: Chemical structures of MPD and the three structural analogs MPC-1, MPC-2, and MPC-3. The molecular probes MPC-1 and MPC-3 are
photoclickable derivatives, whereas the probe MPC-2 bears a fluorescent tag.
use of photoreactive, clickable MPD mimics. As such, an
attempt already showed great promise in a previous report by
Rush et al. from 2015 [10]. Similarly, we envisioned that these
analogs could be used to capture MPD-recognizing proteins,
including the scramblase, from a crude mixture of ER mem-
brane proteins [11,12]. The captured proteins would be subse-
quently identified by mass spectrometry, and their function in
MPD scrambling validated by biochemical and genetic ap-
proaches.
A suitable molecular probe and mimic of MPD (Figure 1) can
be subdivided into three essential components: a β-ᴅ-mannose
(the α-anomer also shows biological activity, but to a lesser
extent) [13-15], a short-chain (citronellol) mimic of dolichol
[1,2,13], and a functional tag. The latter may either be a chemi-
cally reactive group (in MPC-1) or a fluorescent reporter group
(in MPC-2). MPC-1 bears a benzophenone moiety for
photocrosslinking to MPD-recognizing proteins. The presence
of an additional propargyl group provides a way to further
derivatize the probe with biotin azide via click-type chemistry
[16] for the isolation of protein–lipid adducts using streptavidin
resins [10]. To synthesize such molecular probes, previous
studies relied on a chemoenzymatic approach to selectively in-
corporate the biologically relevant β-configured ᴅ-mannose
headgroup as chemical approaches were deemed to be too
challenging [10,13]. This method naturally has some limita-
tions regarding the quantity of the obtained compound and
the availability of the required mannosyltransferase. Here,
we describe a purely chemical approach to synthesize a
photoclickable MPD analog containing β-ᴅ-mannose (in MPC-
1). The chemical synthesis allows for a rapid upscaling of the
reactions if necessary. In addition, having access to the indi-
vidual building blocks (e.g., the phosphoramidites) will enable
the creation of a series of molecular probes with different func-
tional groups and varying linker lengths with relatively little
effort.
The crucial step in the synthetic pathway consists of the conver-
sion of the carbohydrate intermediates into stereodefined,
anomeric phosphoramidite derivatives. The method is based on
adapted procedures developed for DNA solid-phase synthesis
[17]. Phosphoramidite chemistry allows the connection of two
molecular entities via a phosphodiester linkage and was found
to be perfectly suited for this purpose. Reports of using phos-
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Figure 2: Chemical structures of commercially available (S)-citronellol (Cit), 4,4′-dihydroxybenzophenone (BZP), ᴅ-mannose (Man), and 1,12-dode-
canediol (Dod), the main starting materials in the synthesis of MPC-1 and MPC-2.
phoramidite chemistry for the preparation of carbohydrates via
the anomeric position are relatively rare [18-23]. Alternatively,
the H-phosphonate approach has been used to convert carbo-
hydrates into phosphate-linked derivatives at the anomeric
center [24-29].
The phosphoramidite approach was also applied to the synthe-
sis of a second molecular probe, MPC-2, an anomerically pure,
β-linked ᴅ-mannosephosphate derivative, which serves as a
fluorescent MPD analog for scramblase activity screening
assays. Although similar experiments have been described with
radioactively labeled substrates, the use of fluorescently labeled
probes offers several advantages, including the continuous mon-
itoring of the transport and a better time resolution. For reasons
of comparison, the α-configured ᴅ-mannose probe MPC-3 was
synthesized in parallel. The characterization of the configura-
tion at the anomeric position was done by HSQC NMR (see
Supporting Information File 1). Since the target enzymes are
unknown and can be expected to have stereospecific binding
sites, the α-configured ᴅ-mannose probe MPC-3 is also impor-
tant as a reference for our biochemical assays (work in
progress). The possibility to use both probes, MPC-1 and
MPC-3, independently may help to reduce false-positive scram-
blase candidates.
Results and Discussion
The synthesis of the target compounds MPC-1 and MPC-2
started from commercially available (S)-citronellol (Cit), 4,4′-
dihydroxybenzophenone (BZP), D-mannose (Man), and 1,12-
dodecanediol (Dod, Figure 2).
Both the mannose and the phosphodiester bond were intro-
duced via phosphoramidite chemistry to yield the final com-
pounds, as shown in Figure 3. As opposed to the photoclick-
able probe MPC-1, the 4-chloro-7-nitro-1,2,3-benzoxadiazole
(NBD)-labeled analog MPC-2 carries an additional dodecanyl
linker between the citronellyl unit and the fluorophore. This is
intended to increase the hydrophobic interactions between the
probe and the lipid bilayer and also to increase the flexibility.
More specifically, the probe should adopt a U-shaped structure
in which the citronellyl–dodecanyl linker is located in the phos-
pholipid membrane, and the mannose and the NBD are posi-
tioned in the surrounding aqueous medium. The close prox-
imity of the NBD fluorophore to the membrane–water interface
[30,31] allows for fluorescence-based scramblase assays
wherein the NBD can be detected with dithionite. The latter
reduces the nitro group of the NBD rapidly into an amino
group, rendering the fluorophore nonfluorescent [32-34]. While
there are no noteworthy difficulties in the synthesis of the mo-
lecular probe MPC-1 to report, the same cannot be said for
MPC-2. There, the NBD tag was only partially stable to the
conditions used to remove the protecting groups in the final step
(NH3 in MeOH, Figure 3). Under such alkaline conditions, a
considerable amount of degradation of NBD was observed,
making an additional purification step necessary to obtain pure
MPC-2 (see Supporting Information File 1).
As shown in Figure 3, the acetylated mannose phosphoramidite
β-4Ac-Man-CEP was coupled to the free hydroxy group of the
citronellol derivatives containing the functional tags (Cit-BZP-
yne or Cit-Dod-NBD). The reactions were performed in
dichloromethane (DCM), and ETT served as the activator. The
subsequent oxidation of the unstable phosphite triester to the
more stable phosphotriester was performed with t-BuOOH. The
resulting intermediates were then treated overnight with a solu-
tion of ammonia in methanol to remove the protecting groups.
An overall yield of about 45% was achieved when no further
purification was carried out (for details see Supporting Informa-
tion File 1).
The major goal of this work was the synthesis of molecular
probes with a configurationally defined mannosyl headgroup,
i.e., a pure β-anomer. In order to verify the preferred configura-
tion at the anomeric position and to prove the working prin-
ciple of our synthetic strategy, we used 2D NMR experiments.
Coupled HSQC measurements revealed the 1JCH coupling con-
stants of our compounds and thereby the absolute configuration
at the anomeric center of the carbohydrate [40-42]. For MPC-1
and MPC-2, 1JCH values 158 Hz and 161 Hz, respectively,
were obtained (for comparison, for MPC-3 containing almost
exclusively the α-anomer, a value of about 171 Hz was deter-
mined, see Supporting Information File 1).
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Figure 3: The synthetic route leading to compounds MPC-1 and MPC-2. Compound β-4Ac-Man-CEP was prepared in 4 steps from ᴅ-mannose (see
Supporting Information File 1) [35,36]. Compound Cit-BZP-yne was prepared via a Mitsunobu reaction of tetrahydropyranyl (THP)-protected
citronellol and a hydroxylated benzophenone derivative [10,37,38]. Compound Cit-Dod-NBD was obtained in 10 steps, starting from citronellol and
tert-butyldimethylsilyl (TBDMS)-protected dodecanediol [39]. The reaction of either of the alcohols with the sugar phosphoramidite using ETT led to
phosphite intermediates 1a and 1b, respectively. The intermediates were then oxidized with t-BuOOH, and finally, the protecting groups were re-
moved under basic conditions to give either MPC-1 or MPC-2 as ammonium salts. ETT = 5-(ethylthio)-1H-tetrazole.
Figure 4: Preparation of mannosyl phosphoramidites. Starting from 2,3,4,6-tetra-O-acetyl-β-ᴅ-mannopyranose (β-4Ac-Man), the phosphitylation using
2-cyanoethyl N,N-diisopropylchlorophosphoramidite (CEP-Cl) and DIPEA provides β-4Ac-Man-CEP when the reaction is performed at a temperature
below −15 °C (15–30 min reaction time). When the reaction is carried out at room temperature, epimerization leads to 2,3,4,6-tetra-O-acetyl-α-ᴅ-
mannopyranose (not shown), which is subsequently converted to α-4Ac-Man-CEP.
As highlighted above, the most important step in the chemical
synthesis of the target compounds MPC-1 and MPC-2 was the
preparation of the phosphoramidite β-4Ac-Man-CEP
(Figure 4). Two points are of particular importance for the syn-
thesis of this compound. Firstly, we needed access to an
anomerically pure starting material, i.e., 2,3,4,6-tetra-O-acetyl-
β-ᴅ-mannopyranose. This was achieved by following literature
procedures [35,36], which provided the pure β-anomer as a
crystalline solid. Secondly, suitable conditions had to be identi-
fied for the subsequent phosphitylation conditions under which
no mutarotation of the carbohydrate occurs. Cooling of the reac-
tion mixture and performing the reaction at a temperature below
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−15 °C yielded the compound β-4Ac-Man-CEP, with no traces
of the α-anomer. The configuration was then retained through-
out the rest of the synthesis, as indicated by the NMR data of
MPC-1 and MPC-2 (Supporting Information File 1).
Conclusion
We report herein the successful chemical synthesis of molecu-
lar probes for identifying and studying MPD scramblase, as
well as proteins that use MPD as a mannosyl donor. Two types
of probes were synthesized; both are short-chain glycolipid
analogs. One, MPC-1, contains a photoreactive clickable tag to
capture scramblase candidates (identification by mass spectrom-
etry), and the other probe, MPC-2, consists of a fluorescent
label to test candidates for scramblase activity in reconstitution-
based assays. The molecular probes were prepared via phos-
phoramidite chemistry, which allowed the incorporation of the
carbohydrate headgroup and simultaneously introduced the
linking phosphate group. Furthermore, we demonstrate a novel,
reliable, and efficient way to synthesize the carbohydrate phos-
phoramidite with a defined configuration at the anomeric posi-
tion, a strategy that gives access to future molecular probes con-
taining pure β-ᴅ-mannose, which was previously only acces-
sible through a chemoenzymatic approach.
Experimental
Synthesis
Detailed descriptions of the synthesis and the analytical data
(NMR and MS spectra) are provided in Supporting Information
File 1.
Cit-BZP-yne
THP-Cit-BZP-yne (279 mg, 0.57 mmol, 1 equiv) was dis-
solved in anhydrous ethanol (8 mL), and pyridinium p-toluene-
sulfonate (PPTS, 286 mg, 1.14 mmol, 2 equiv) was added. The
solution was stirred at 60 °C for 2.5 h. The reaction mixture (at
rt) was poured into a separating funnel containing diethyl ether
(40 mL) and brine (16 mL). The organic layer was dried over
MgSO4, and the volatile components were removed under
reduced pressure. The yellowish residue (crude product) was
purified by flash chromatography over silica gel, with a mix-
ture of n-hexane/ethyl acetate 3:2, v/v as eluent. The fractions
containing the product (Rf = 0.22 in n-hexane/ethyl acetate 3:2,
v/v) were combined, and the solvents were removed under
reduced pressure on a rotary evaporator to give Cit-BZP-yne
(154 mg, 0.38 mmol, 67%) as white solid. 1H NMR (300 MHz,
CDCl3, δ):7.85–7.72 (m, 4H), 7.09–6.99 (m, 2H), 7.02–6.91 (m,
2H), 5.61–5.49 (m, 1H), 4.77 (d, J = 2.4 Hz, 2H), 4.47 (s, 2H),
3.69 (m, 2H), 2.56 (t, J = 2.4 Hz, 1H), 2.21–1.98 (m, 2H), 1.74
(s, 3H), 1.70–1.50 (m, 1H), 1.50–1.15 (m, 4H), 0.92 (d, J =
6.4 Hz, 3H); 13C NMR (75 MHz, CDCl3, δ) 194.48, 162.39,
160.64, 132.22, 132.14, 131.64, 130.51, 130.29, 129.82, 114.37,
114.36, 77.92, 76.10, 74.21, 61.12, 55.89, 39.83, 36.63, 29.18,
25.20, 19.46, 13.85.
β-4Ac-Man-CEP
β-4Ac-Man (100 mg, 0.29 mmol, 1 equiv) was dissolved in an-
hydrous DCM (4 mL) at −60 °C. Then, DIPEA (75 μL,
0.43 mmol, 1.5 equiv) was added, followed by the addition of
CEP-Cl (77 μL, 0.35 mmol, 1.2 equiv). The mixture was stirred
for 30 min at −50 °C under argon. The crude product was then
directly purified by flash chromatography using ethyl acetate/n-
hexane 1:1, v/v + 2% triethylamine. The fractions containing
the product (Rf = 0.40) were combined, and the solvents were
removed under reduced pressure on a rotary evaporator. The
product was extensively dried to give β-4Ac-Man-CEP
(145 mg, 0.26 mmol, 92%) as colorless foam. 1H NMR
(300 MHz, CDCl3, δ) 5.37 (dd, J = 25.2, 3.3 Hz, 1H), 5.19 (t,
J = 9.9 Hz, 1H), 5.12–4.95 (m, 2H), 4.24–4.09 (m, 2H),
3.91–3.48 (m, 5H), 2.66–2.53 (m, 2H), 2.14 (s, 3H), 2.05–2.00
(m, 8H), 1.95 (d, J = 1.6 Hz, 3H), 1.12 (dd, J = 10.8; 6.9 Hz,
12H); 13C NMR (75 MHz, CDCl3, δ): 170.58, 170.55, 170.31,
170.10, 169.98, 169.94, 169.67, 169.63, 117.63, 93.69, 93.57,
93.36, 72.72, 72.66, 70.98, 69.78, 69.69, 65.99, 65.90, 62.67,
62.43, 59.20, 58.96, 58.78, 58.53, 44.07, 43.90, 43.77, 43.59,
24.61, 24.52, 24.43, 24.34, 24.04, 23.94, 20.80, 20.77, 20.68,
20.56, 20.34, 20.25, 20.14, 20.06; 31P NMR (121 MHz, CDCl3,
δ) 153.31, 150.00.
MPC-1
ETT (72 mg, 0.55 mmol, 1.5 equiv) was dissolved in an-
hydrous DCM (2 mL), β-4Ac-Man-CEP (223 mg, 0.41 mmol,
1.1 equiv) was added, and the resultant solution was added to a
solution of Cit-BZP-yne (150 mg, 0.37 mmol, 1 equiv) dis-
solved in anhydrous DCM (2 mL). The reaction mixture was
stirred for 30 min at rt under argon. Afterwards, a t-BuOOH
solution (201 μL, 1.11 mmol, 3 equiv, ≈5.5 M in decane) was
added, and the mixture was stirred for an additional 15 min. The
reaction mixture was diluted with toluene (60 mL) and then
washed with a saturated sodium hydrogen carbonate solution
(30 mL) and brine (30 mL). The organic layer was dried over
MgSO4, and the volatile components were removed under
reduced pressure. The resulting residue was dissolved in metha-
nol and purified by PLC (using ethyl acetate/n-hexane 2:1, v/v
as a mobile phase). The broad band, located at the very bottom
of the plate (Rf ≈ 0.10 using ethyl acetate/n-hexane 1:1, v/v)
was removed, and the intermediate β-4Ac-Man-P-Cit-BZP-
yne was extracted with methanol (150 mL). The solvent was re-
moved under reduced pressure on a rotary evaporator. Then, an
ammonia solution (3 mL, 2.0 M in methanol) was added, and
the reaction mixture was stirred overnight at rt. The resulting
solution was first diluted with methanol (2 mL), and the vola-
tile components were removed under reduced pressure. Then,
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distilled water (2 mL) was added, and the material was
lyophilized overnight to afford MPC-1 (110 mg, 0.17 mmol,
46%) as yellowish solid. 1H NMR (400 MHz, DMSO-d6, δ)
7.75–7.66 (m, 4H), 7.17–7.04 (m, 4H), 5.58 (t, J = 6.7 Hz, 1H),
4.92 (d, J = 2.4 Hz, 2H), 4.87 (d, J = 8.5 Hz, 1H), 4.51 (s, 2H),
3.77–3.61 (m, 5H), 3.62–3.32 (m, 2H), 3.33–3.25 (m, 2H), 2.05
(m, 2H), 1.69 (s, 3H), 1.62–1.48 (m, 2H), 1.42–1.26 (m, 2H),
1.26–1.13 (m, 1H), 0.87 (d, J = 6.2 Hz, 3H); 13C NMR
(101 MHz, DMSO-d6, δ) 193.64, 162.46, 160.86, 132.29,
132.13, 131.24, 130.63, 130.30, 129.66, 115.07, 115.02, 96.07,
96.04, 79.25, 79.20, 74.05, 73.98, 71.53, 71.48, 67.39, 63.02,
62.97, 61.82, 56.20, 37.85, 37.78, 36.76, 36.36, 29.33, 25.14,
19.69, 14.17; 31P NMR (121 MHz, DMSO-d6, δ) 25.54, 4.74,
−2.89.
Cit-Dod-NBD
DMT-Cit-Dod-NBD (787 mg, 0.96 mmol) was dissolved in a
trichloroacetic acid solution (3% in DCM/MeOH 1:1, v/v) at rt.
The reaction mixture was stirred for 2 h. The mixture was
diluted with DCM, washed with brine, and the organic phase
was dried with Na2SO4. The purification by column chromatog-
raphy on silica gel (hexane/EtOAc 6:4, v/v) gave Cit-Dod-NBD
(455 mg, 92%) as red oil (Rf = 0.5 in hexane/EtOAc 1:1, v/v).
1H NMR (DMSO-d6, 300 MHz, δ) 9.55 (s, 1H), 8.50 (d, J =
8.8 Hz, 1H), 6.49–6.31 (m, 1H), 5.33 (t, J = 7.2 Hz, 1H), 4.28
(t, J = 5.1 Hz, 1H), 3.73 (s, 2H), 3.59–3.36 (m, 4H), 3.26 (t, J =
6.4 Hz, 2H), 1.74–1.61 (m, 2H), 1.55 (s, 3H), 1.52–1.40 (m,
4H), 1.24 (s, 19H), 0.84 (d, J = 6.5 Hz, 3H); 13C NMR (DMSO-
d6, 75 MHz, δ) 132.41, 127.51, 99.47, 79.67, 76.21, 69.19,
63.78, 59.24, 37.01, 33.97, 30.68, 29.63, 29.47, 29.42, 29.18,
28.81, 28.06, 26.85, 26.19, 25.00, 24.92, 19.86, 19.09, 14.06,
13.99.
MPC-2
ETT (38 mg, 0.29 mmol, 1.5 equiv) was dissolved in an-
hydrous DCM (2 mL), β-4Ac-Man-CEP (116 mg, 0.21 mmol,
1.1 equiv) was added, and the resultant solution was added to
Cit-Dod-NBD (100 mg, 0.19 mmol, 1 equiv) dissolved in an-
hydrous DCM (1 mL). The reaction mixture was stirred for
30 min at rt under argon. Afterwards, a t-BuOOH solution
(110 μL, 0.61 mmol, 3 equiv, ≈5.5 M in decane) was added, and
the mixture was stirred for an additional 15 min. The reaction
mixture was poured into a separating funnel containing DCM
(15 mL) and a saturated sodium hydrogen carbonate solution
(15 mL). The organic layer was further washed with brine
(15 mL) and then dried with MgSO4. The volatile components
were removed under reduced pressure, the brownish residue
was redissolved in acetonitrile (1.5 mL) and purified by PLC
(using a mixture of ethyl acetate/n-hexane 1:1, v/v as the mobile
phase). The broad band located at the very bottom of the plate
(Rf ≈ 0.10 using ethyl acetate/n-hexane 1:1, v/v) was removed,
and the intermediate β-4Ac-Man-P-Cit-Dod-NBD was
extracted with acetonitrile (180 mL). The solvent was removed
under reduced pressure on a rotary evaporator. The material was
then treated overnight with an ammonia solution (2 mL, 2.0 M
in methanol). Afterwards, the reaction mixture was diluted with
methanol (2 mL), the volatile components were removed under
reduced pressure, and the orange-brownish residue (redissolved
in 1.5 mL methanol) was purified by PLC (using chloroform/
methanol/water 60:25:4, v/v/v as the mobile phase). The broad
band, centered at around an Rf of about 0.22, was removed, and
the product was extracted with methanol (170 mL). The solvent
was removed under reduced pressure on a rotary evaporator, the
residue dissolved in distilled water (1.3 mL), and the material
was lyophilized overnight to give MPC-2 (65 mg, 0.09 mmol,
45%). 1H NMR (300 MHz, D2O, δ) 8.27 (s, 1H), 6.17 (s, 1H),
5.35 (s, 1H), 5.13 (d, J = 8.4 Hz, 1H), 4.14–3.53 (m, 10H),
3.50–3.19 (m, 4H), 2.05–1.99 (m, 2H), 1.78–1.42 (m, 9H),
1.33–1.08 (m, 21H), 0.91 (d, J = 6.0 Hz, 3H); 13C NMR
(101 MHz, D2O, δ) 131.98, 131.89, 131.83, 128.40, 128.33,
95.42, 95.38, 76.90, 76.65, 72.73, 71.17, 71.12, 69.33, 69.32,
66.19, 64.79, 61.20, 60.82, 37.11, 29.76, 29.61, 29.52, 29.39,
29.23, 26.26, 25.09, 18.99, 13.57; 31P NMR (121 MHz, D2O, δ)
7.22, −1.64.
MPC-3
Compound α-4Ac-Man-CEP was prepared according to
published procedures [22] (for more information see Support-
ing Information File 1).
α-4Ac-Man-CEP (252 mg, 0.46 mmol, 1.1 equiv) and ETT
(82 mg, 0.63 mmol, 1.5 equiv) were dissolved in anhydrous
DCM (1 mL) and Cit-BZP-yne (170 mg, 0.42 mmol, 1 equiv,
dissolved in 1.5 mL anhydrous DCM) was added. The reaction
mixture was stirred for 30 min at rt under argon. Afterwards, a
t-BuOOH solution (182 μL, 1.31 mmol, 3 equiv, 70 wt % in
H2O) was added, and the solution was stirred for an additional
15 min. The reaction mixture was diluted with toluene (15 mL)
and poured into a separating funnel containing a saturated sodi-
um hydrogen carbonate solution (10 mL). The organic phase
was washed with brine, dried with MgSO4, and the volatile
components were removed under reduced pressure. The result-
ing material was then dissolved in DCM and purified by flash
chromatography on silica gel using ethyl acetate/n-hexane 7:3,
v/v as eluent. The fractions containing the intermediate α-4Ac-
Man-P-Cit-BZP-yne (Rf = 0.33 using the same solvent system
as for the column) were combined, and the solvents were re-
moved under reduced pressure on a rotary evaporator. To the
white residue, an ammonia solution (4 mL, 2.0 M in methanol)
was added, and the reaction mixture was stirred overnight at rt.
Afterwards, the volatile components were removed under
reduced pressure, the residue was dissolved in methanol (2 mL),
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and the material was purified by PLC (using chloroform/metha-
nol/water 60:25:4, v/v/v as the mobile phase). The broad band,
centered at around Rf ≈ 0.19, was removed, and the product was
extracted with methanol (100 mL). The solvent was removed
under reduced pressure on a rotary evaporator to give MPC-3
(65 mg, 0.10 mmol, 24%) as white solid. 1H NMR (400 MHz,
DMSO-d6, δ) 7.75–7.64 (m, 4H), 7.16–7.04 (m, 4H), 5.58 (t,
J = 7.2 Hz, 1H), 5.17 (dd, J = 7.8, 1.9 Hz, 1H), 4.91 (d, J =
2.4 Hz, 2H), 4.88–4.87 (m, 3H), 4.76–4.71 (m, 2H), 4.50 (s,
2H), 3.77–3.63 (m, 2H), 3.63–3.51 (m, 4H), 3.42–3.23 (m, 2H),
2.04 (m, 2H), 1.69 (s, 3H), 1.60–1.45 (m, 2H), 1.41–1.24 (m,
2H), 1.24–1.10 (m, 1H), 0.85 (d, J = 6.4 Hz, 3H); 13C NMR
(101 MHz, DMSO-d6, δ) 193.74, 162.47, 160.84, 132.31,
132.15, 131.22, 130.61, 130.26, 129.71, 115.07, 115.03, 96.05,
95.99, 79.24, 79.14, 74.51, 74.06, 71.46, 71.38, 70.92, 67.64,
62.81, 62.76, 61.80, 56.17, 37.90, 37.83, 36.75, 29.30, 25.11,
19.68, 14.16; 31P NMR (121 MHz, DMSO-d6, δ) −2.86.
Supporting Information
Supporting Information File 1
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